The L-asparaginase enzyme catalyzes the conversion of amino acid L-asparagine into L-aspartic acid and ammonia, and is considered an essential pharmaceutical agent in the treatment of ALL in children. This evidence concerns the gene ASPG and acute lymphoblastic leukemia.